Earnings Call · Q2 FY2024·2024-08-05

Q2 24EPS +59.24%·Rev n/aQ1 24EPS +12.28%·Rev n/aQ4 23EPS +67.68%·Rev n/aQ3 23EPS +62.58%·Rev n/a⚠ consensus missing

Arcturus Therapeutics Holdings Inc. ARCT

Neda Safarzadeh — Investor Relations

Joe Payne — President and Chief Executive Officer (CEO)

Andy Sassine — Chief Financial Officer (CFO)

+0.2%1d on move date−0.7% vs SPY3d−5.1%5d−4.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARCT calls or request research access.

More ARCT calls Browse calls Request research access